Company: TAK
Filing Date: 2025-07-30
Form Type: 6-K
Source: 0001395064-25-000120
Chunk: 12

Company: TAKEDA PHARMACEUTICAL CO LTD
Filing Date: 2025-07-30
Form: 6-K
Chunk 12
---
 2024.

Share of Loss of Investments Accounted for Using the Equity Method

Share of Loss of Investments Accounted for Using the Equity Method was JPY 0.5 billion (JPY -0.2 billion and -24.7% AER, -69.6% CER).

<div align='center'>5</div>

Takeda Pharmaceutical Company Limited (4502)

Earnings Report ( Kessan Tanshin ) for the Three-month

Period Ended June 30, 2025 (Consolidated)

#### Income Tax Expenses
Income Tax Expenses were JPY 26.4 billion (JPY -15.0 billion and -36.2% AER , -32.9% CER ). The decrease was primarily due to the effect of a higher valuation allowance on deferred tax assets recognized during the three-month period ended June 30, 2024 partially offset by an increase in tax expenses due to lower level of tax credits recognized during the three-month period ended June 30, 2025 .

#### Net Profit for the Period
As a result of the above factors, Net Profit for the Period was JPY 124.3 billion ( JPY +29.0 billion and +30.4% AER , +34.5% CER ) and Net Profit for the Period attributable to owners of the Company was JPY 124.2 billion ( JPY +29.0 billion and +30.4% AER, +34.5% CER).

<div align='center'>6</div>

Takeda Pharmaceutical Company Limited (4502)

Earnings Report ( Kessan Tanshin ) for the Three-month

Period Ended June 30, 2025 (Consolidated)

(ii) Results of Core Financial Measures (April 1 to June 30, 2025)

Definition and Explanation of Core Financial Measures and Constant Exchange Rate Change

In addition to the financial statements in accordance with IFRS, Takeda uses the concept of Core Financial Measures for measuring financial performance. These measures are not defined by International Financial Reporting Standards (IFRS). See “Definition and Explanation of Non-IFRS Measures and U.S. Dollar Convenience Translations” in the Financial Appendix for additional information.

#### Results of Core Operations
|                                                                      |     |           |         |     |            |         |     |          |        |     |          |       |   |     |     |       | Billion JPY or percentage |
|